{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:20:18Z","timestamp":1787026818540,"version":"build-2736575974"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00534","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:53:35Z","timestamp":1591750415000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA"],"prefix":"10.3389","volume":"11","author":[{"given":"Yingying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"l895","DOI":"10.1136\/bmj.l895","article-title":"Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack","volume":"364","author":"Wang","year":"2019","journal-title":"BMJ."},{"key":"B3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the american heart association\/american stroke association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke."},{"key":"B5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1136\/svn-2018-000168","article-title":"Dual vs. mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis","volume":"3","author":"Yang","year":"2018","journal-title":"Stroke Vasc Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/ane.12111","article-title":"Clinical consequences of aspirin and clopidogrel resistance: an overview","volume":"128","author":"Mijajlovic","year":"2013","journal-title":"Acta Neurol Scand."},{"key":"B7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/CIRCGENETICS.110.958561","article-title":"First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor vs. clopidogrel: the ONSET\/OFFSET and RESPOND genotype studies","volume":"3","author":"Tantry","year":"2010","journal-title":"Circ Cardiovasc Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s40262-015-0290-2","article-title":"Ticagrelor: pharmacokinetic, pharmacodynamic and pharmacogenetic profile: an update","volume":"54","author":"Teng","year":"2015","journal-title":"Clin Pharmacokin."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor vs. clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/s0140-6736(10)61274-3","article-title":"Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor vs. clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor vs. clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1603060","article-title":"Ticagrelor vs. aspirin in acute stroke or transient ischemic attack","volume":"375","author":"Johnston","year":"2016","journal-title":"N Engl J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1177\/1747493019830307","article-title":"The acute sroke or transient iscemic attack treated with ticgreor and aspirin for prvention of troke and death (THALES) trial: rationale and design","volume":"14","author":"Johnston","year":"2019","journal-title":"Int J Stroke."},{"key":"B16","doi-asserted-by":"publisher","first-page":"l2211","DOI":"10.1136\/bmj.l2211","article-title":"Ticagrelor plus aspirin vs. clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial","volume":"365","author":"Wang","year":"2019","journal-title":"BMJ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/s0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jacc.2008.06.038","article-title":"Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study","volume":"52","author":"Patti","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/09537104.2013.865835","article-title":"Comparison between a new platelet count drop method PL-11, light transmission aggregometry, VerifyNow aspirin system and thromboelastography for monitoring short-term aspirin effects in healthy individuals","volume":"26","author":"Guan","year":"2015","journal-title":"Platelets."},{"key":"B20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1177\/1747493017694390","article-title":"Effect of ticagrelor with clopidogrel on high on-treatment platelet reactivity in acute stroke or transient ischemic attack (PRINCE) trial: Rationale and design","volume":"12","author":"Wang","year":"2017","journal-title":"Int J Stroke."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3504950","DOI":"10.1155\/2017\/3504950","article-title":"Adequate platelet function inhibition confirmed by two inductive agents predicts lower recurrence of ischemic stroke\/transient ischemic attack","volume":"2017","author":"Zhang","year":"2017","journal-title":"Biomed Res Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1093\/eurheartj\/ehr422","article-title":"Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient outcomes (PLATO) trial","volume":"32","author":"Becker","year":"2011","journal-title":"Eur Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/circulationaha.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12872-016-0394-0","article-title":"High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Cardiovasc Dis."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:53:37Z","timestamp":1591750417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":25,"alternative-id":["10.3389\/fneur.2020.00534"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00534","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"article-number":"534"}}